Intestinal Parasites in Sheep: Worms and Their Management

Introduction

Intestinal parasitism in sheep represents a major constraint to global small ruminant production, causing substantial economic losses through reduced weight gain, decreased wool quality, impaired reproductive performance, and mortality in severe cases. The term "worms sheep get" encompasses a diverse assemblage of helminth taxa, primarily within the phylum Nematoda, that inhabit the gastrointestinal tract. These parasites impose a continuous metabolic burden on the host, and their management requires an integrated understanding of parasite biology, host physiology, and environmental epidemiology. This article provides a detailed clinical and scientific reference on the etiology, epidemiology, clinical signs, pathology, diagnostic approaches, treatment protocols, and control strategies for intestinal nematodes in sheep.

Etiology and Classification

The principal intestinal nematodes affecting sheep belong to the order Strongylida, with additional contributions from Ascaridida and Cestoda. The most economically significant genera include Haemonchus, Teladorsagia, Trichostrongylus, Nematodirus, Cooperia, Oesophagostomum, and Chabertia. The tapeworm Moniezia expansa (order Cyclophyllidea) is also commonly encountered in lambs.

Table 1. Major Intestinal Helminths of Sheep and Their Predominant Anatomical Location

Epidemiology and Life Cycles

All gastrointestinal nematodes of sheep share a direct life cycle, with the exception of cestodes which require an intermediate oribatid mite host. Adult female nematodes in the gastrointestinal lumen produce eggs that are passed in the feces. Under appropriate environmental conditions of moisture and temperature, eggs hatch to release first-stage larvae (L1), which develop through second-stage (L2) to the infective third-stage (L3). The L3 migrate onto herbage where they are ingested by grazing sheep. Following ingestion, exsheathment occurs in the rumen or abomasum, and larvae undergo further molts to become adults.

The periparturient rise (PPR) is a critical epidemiological phenomenon wherein ewes exhibit a transient increase in fecal egg counts (FEC) around lambing. This rise is driven by a combination of hormonal immunosuppression and nutritional stress, and it serves as the primary source of pasture contamination for susceptible lambs. Nematodirus battus exhibits a unique epidemiology: eggs require a prolonged cold period followed by spring warming to hatch, leading to a synchronous emergence of L3 that coincides with the first grazing season of lambs.

Clinical Signs and Pathophysiology

Clinical manifestations of intestinal parasitism depend on the parasite species, burden intensity, host age, and nutritional status. Subclinical infections are far more common than overt disease but still impose significant production losses.

Anemia and Hypoproteinemia. Haemonchus contortus is a blood-feeding parasite; each adult worm can consume approximately 0.05 mL of blood per day. Heavy burdens cause progressive anemia, pale mucous membranes, submandibular edema (bottle jaw), and weakness. The FAMACHA system, which scores ocular mucous membrane color on a 1 to 5 scale, is a validated field tool for detecting haemonchosis-associated anemia.

Diarrhea and Weight Loss. Trichostrongylus spp. and Teladorsagia circumcincta induce a protein-losing enteropathy characterized by villous atrophy, crypt hyperplasia, and increased mucosal permeability. Affected animals develop profuse watery diarrhea (scours), dehydration, hypoproteinemia, and rapid weight loss. In lambs, Nematodirus battus infection causes a severe, often fatal, enteritis with sudden onset of diarrhea, dehydration, and recumbency.

Reduced Growth and Wool Quality. Even in the absence of overt clinical signs, subclinical parasitism reduces feed conversion efficiency. Protein and energy that would otherwise be allocated to muscle accretion and wool fiber synthesis are diverted to immune responses, tissue repair, and endogenous protein loss. This results in reduced average daily gain and lower fleece weights.

Pathology

Gross pathological findings at necropsy vary by parasite species. In haemonchosis, the abomasal mucosa appears hyperemic with visible adult worms (resembling barber pole stripes due to the white reproductive tract coiled around the blood-filled intestine). Abomasal contents are often fluid and blood-tinged. In trichostrongylosis, the small intestinal wall is thickened, edematous, and hyperemic, with liquid intestinal contents. Oesophagostomum infection produces characteristic raised nodules (1-4 mm) in the large intestinal wall, representing granulomatous reactions to larval stages. Chabertia ovina causes a severe hemorrhagic typhlocolitis with mucosal ulceration and diphtheritic membrane formation.

Histologically, the abomasum in teladorsagiosis shows hyperplasia of mucous neck cells, loss of parietal cells, and infiltration of eosinophils and mast cells. In the small intestine, trichostrongylosis is characterized by villous blunting, crypt elongation, and increased numbers of goblet cells and intraepithelial lymphocytes.

Diagnostics

Accurate diagnosis is essential for targeted treatment and resistance monitoring. The cornerstone of antemortem diagnosis is the quantitative fecal egg count (FEC) using the modified McMaster technique. This method involves flotation of feces in a saturated salt or sugar solution (specific gravity 1.20-1.30) and enumeration of eggs in a counting chamber. Results are expressed as eggs per gram (EPG) of feces. The sensitivity of the McMaster method is approximately 50 EPG, which is adequate for detecting moderate to high burdens but may miss low-level infections.

Table 2. Common Diagnostic Methods for Ovine Intestinal Nematodes

Larval culture is necessary for genus-level identification because nematode eggs are morphologically similar. Feces are incubated at 22-27 degrees Celsius for 7-10 days, and third-stage larvae are recovered by the Baermann technique. Larval morphology (sheath tail length, number of intestinal cells, total length) allows differentiation of Haemonchus, Teladorsagia, Trichostrongylus, Cooperia, Oesophagostomum, and Chabertia.

Molecular diagnostics, including conventional PCR and quantitative real-time PCR (qPCR), offer species-specific detection and quantification. These assays target ribosomal DNA (ITS-2 region) or mitochondrial genes (e.g., cox1). Pooled fecal PCR testing enables cost-effective screening of flock-level parasite burdens and detection of anthelmintic resistance-associated mutations (e.g., benzimidazole resistance-associated SNPs in the beta-tubulin isotype 1 gene).

Treatment: Anthelmintic Strategies

Anthelmintic therapy remains the primary intervention for clinical parasitism. Three major classes of broad-spectrum anthelmintics are available for sheep: benzimidazoles (e.g., albendazole, fenbendazole), macrocyclic lactones (e.g., ivermectin, moxidectin), and imidazothiazoles/tetrahydropyrimidines (e.g., levamisole, morantel). Monepantel, a member of the amino-acetonitrile derivative (AAD) class, and derquantel, a spiroindole, represent newer options.

Table 3. Anthelmintic Classes and Mechanisms of Action

Treatment decisions should be guided by FEC results and clinical assessment. Targeted selective treatment (TST) protocols, in which only animals exceeding a predetermined FEC threshold are treated, reduce selection pressure for resistance. For Haemonchus contortus, the FAMACHA system enables identification of anemic individuals requiring treatment while leaving non-anemic animals untreated.

Anthelmintic Resistance

Anthelmintic resistance (AR) is the single greatest threat to sustainable worm control in sheep. Resistance has been documented globally in all major nematode species and against all anthelmintic classes. The molecular mechanisms include target site mutations (e.g., beta-tubulin polymorphisms for benzimidazole resistance), increased drug efflux via P-glycoprotein transporters (macrocyclic lactone resistance), and altered receptor expression.

Detection of AR relies on the fecal egg count reduction test (FECRT). A reduction of less than 95% in mean FEC at 10-14 days post-treatment, with a lower 95% confidence interval below 90%, indicates resistance. Molecular assays for resistance-associated alleles (e.g., the F200Y mutation in H. contortus beta-tubulin) are increasingly used for early detection.

Integrated Parasite Control

Sustainable management of intestinal parasites requires an integrated approach combining grazing management, nutritional support, genetic selection, and judicious anthelmintic use.

Grazing Management. Pasture contamination can be reduced by rotational grazing, mixed species grazing (e.g., sheep with cattle), and avoiding grazing of high-risk pastures (e.g., those grazed by lambs in the previous season). Rest periods of 6-8 weeks during warm, dry weather reduce L3 survival on pasture. Nematodirus battus control relies on avoiding spring grazing of pastures contaminated the previous year.

Genetic Selection. Sheep breeds and individuals vary in their resistance to nematode infection, as measured by FEC. Selection for low FEC is heritable (h^2 = 0.2-0.4) and can reduce pasture contamination over generations. Some breeds, such as the Red Maasai and Gulf Coast Native, exhibit superior resistance to H. contortus.

Nutritional Management. Adequate protein nutrition supports the immune response to nematodes. Supplementation with bypass protein (e.g., fish meal, cottonseed meal) during the periparturient period reduces the magnitude of the PPR and improves lamb growth rates.

Biological Control. The nematophagous fungus Duddingtonia flagrans produces spores that trap and kill nematode larvae in feces. When fed to sheep, spores pass through the gastrointestinal tract and germinate in fecal pats, reducing L3 emergence onto pasture.

The following Mermaid diagram illustrates a decision framework for integrated parasite management.

flowchart TD
    A[Flock Monitoring], > B{FEC > Threshold?}
    B, >|Yes| C[Clinical Assessment]
    B, >|No| D[Continue Monitoring]
    C, > E{Anemia Present?}
    E, >|Yes| F[Treat with Anthelmintic]
    E, >|No| G[TST: Treat only high-FEC animals]
    F, > H[Post-Treatment FECRT at 14 days]
    G, > H
    H, > I{Reduction > 95%?}
    I, >|Yes| J[Effective treatment]
    I, >|No| K[Suspect Resistance]
    K, > L[Confirm via molecular assay]
    L, > M[Switch Anthelmintic Class]
    M, > N[Implement grazing management]
    N, > O[Select for low-FEC genetics]
    O, > A

Conclusion

Intestinal parasites remain a persistent challenge in sheep production systems worldwide. The worms sheep get are diverse in their biology, pathogenic mechanisms, and epidemiological patterns. Effective management requires a multifaceted approach that integrates accurate diagnostics, targeted treatment protocols, grazing management, genetic selection, and nutritional support. The escalating threat of anthelmintic resistance demands a shift from routine mass treatment to evidence-based, selective intervention strategies. Continued research into vaccine development, novel drug targets, and precision diagnostic tools will be essential for the long-term sustainability of ovine parasite control.

References

1. Besier RB, Kahn LP, Sargison ND, Van Wyk JA. Diagnosis, treatment and management of Haemonchus contortus in small ruminants. Advances in Parasitology. 2016;93:181-238.
2. Coles GC, Jackson F, Pomroy WE, Prichard RK, von Samson-Himmelstjerna G, Silvestre A, Taylor MA, Vercruysse J. The detection of anthelmintic resistance in nematodes of veterinary importance. Veterinary Parasitology. 2006;136(3-4):167-185.
3. Kaplan RM. Biology, epidemiology, diagnosis, and management of anthelmintic resistance in gastrointestinal nematodes of livestock. Veterinary Clinics of North America: Food Animal Practice. 2020;36(1):17-30.
4. Kenyon F, Greer AW, Coles GC, Cringoli G, Papadopoulos E, Cabaret J, Berrag B, Varady M, Van Wyk JA, Thomas E, Vercruysse J, Jackson F. The role of targeted selective treatments in the development of refugia-based approaches to the control of gastrointestinal nematodes of small ruminants. Veterinary Parasitology. 2009;164(1):3-11.
5. Knox MR, Besier RB, Le Jambre LF, Kaplan RM, Torres-Acosta JF, Miller J, Sutherland I. Novel approaches for the control of gastrointestinal nematode parasites of livestock. Veterinary Parasitology. 2012;186(1-2):79-89.
6. Leathwick DM, Besier RB. The management of anthelmintic resistance in grazing ruminants in Australasia: strategies and experiences. Veterinary Parasitology. 2014;204(1-2):44-54.
7. Roeber F, Jex AR, Gasser RB. Advances in the diagnosis of key gastrointestinal nematode infections of livestock, with an emphasis on small ruminants. Biotechnology Advances. 2013;31(8):1135-1152.
8. Sargison ND. Pharmaceutical control of endoparasitic infections in sheep. Veterinary Clinics of North America: Food Animal Practice. 2011;27(1):139-156.
9. Sutherland IA, Leathwick DM. Anthelmintic resistance in nematode parasites of cattle: a global issue? Trends in Parasitology. 2011;27(4):176-181.
10. Taylor MA, Coop RL, Wall RL. Veterinary Parasitology. 4th ed. Wiley Blackwell; 2016.
11. Van Wyk JA, Bath GF. The FAMACHA system for managing haemonchosis in sheep and goats by clinically identifying individual animals for treatment. Veterinary Research. 2002;33(5):509-529.
12. Vercruysse J, Claerebout E. Treatment vs non-treatment of helminth infections in cattle: defining the threshold. Veterinary Parasitology. 2001;98(1-3):195-214.
13. Waller PJ. From discovery to development: current industry perspectives for the development of novel methods of helminth control in livestock. Veterinary Parasitology. 2006;139(1-3):1-14.
14. Wolstenholme AJ, Fairweather I, Prichard R, von Samson-Himmelstjerna G, Sangster NC. Drug resistance in veterinary helminths. Trends in Parasitology. 2004;20(10):469-476.
15. Zajac AM, Conboy GA. Veterinary Clinical Parasitology. 8th ed. Wiley Blackwell; 2012.

Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.